Aspire Biopharma announces public listing on Nasdaq
Aspire Biopharma (ASBP) and PowerUp Acquisition (PWUP) announced the completion of their previously announced business combination. Proceeds ...
Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development
We are thrilled to have Patrick step into this pivotal role,” said Benedikt von Braunmühl, CEO of Rentschler Biopharma. “Patrick’s in-depth understanding of our clients’ needs, coupled with his ...